NCT00044616View on ClinicalTrials.gov

Relapse Prevention for Bipolar Type-II Disorder

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
Bipolar DisorderDepression
Interventions
DRUG

Fluoxetine

DRUG

Lithium

Trial Locations (1)

19104

Depression Research Unit, Univ Penn, Philadelphia

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

University of Pennsylvania

OTHER

NCT00044616 - Relapse Prevention for Bipolar Type-II Disorder | Biotech Hunter | Biotech Hunter